Can an Effective SARS-CoV-2 Vaccine Be Developed for the Older Population?

Immunity and Ageing - United Kingdom
doi 10.1186/s12979-020-00180-2
Full Text
Abstract

Available in full text

Categories
AgingImmunology
Date
Authors
Publisher

Springer Science and Business Media LLC

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy